RNA, variant U1 small nuclear 7 (RNVU1-7)

RNA, variant U1 small nuclear 7 (RNVU1-7), also known by several aliases such as vU1.7 and RNU1-6P, is a member of the variant U1 small nuclear RNAs (vU1 snRNAs), non-coding RNAs transcribed from what were historically considered U1 snRNA pseudogenes[1][2][4]. RNVU1-7 shares high sequence similarity with canonical U1 snRNA and is involved in pre-mRNA 5′ splice site recognition as part of the U1 small nuclear ribonucleoprotein (snRNP) complex[1][2][4]. Variant U1 snRNAs, including RNVU1-7, are differentially expressed and appear to participate in the regulation of gene expression at the pre-mRNA processing level, including potential roles in alternative splicing or mRNA 3′ end processing[2][4]. However, as a pseudogene-derived non-coding RNA, there is no evidence that RNVU1-7 is a receptor, enzyme, transporter, or other classic therapeutic target, nor is it a direct target for pharmacological agents[2][4]. Its precise functional relevance, outside of general RNA regulation or as a potential regulatory RNA, remains under investigation, and it is not clinically actionable or recognized as a disease biomarker at present[2][4]. \n\nKey context: \n- RNVU1-7 is *not* a protein, and no data support direct drug targeting[1][2][4]. \n- The functional significance of vU1 RNAs is still being explored; some may affect gene regulation, but there is no consensus on specific disease mechanisms, biomarker roles, or therapeutic targeting[2][4][3]. \n- "Pseudogene" in its aliases refers to its origin: sequence similarity to functional genes without canonical translation, but with potential RNA-mediated effects[2][3]. \n- No mechanisms of action or safety concerns apply, as this is not a druggable entity[1][2][4].

Other names

vU1.7vU1.9RNU1-26PRNU1-6RNU1-6PRNU1-9RNU1-9PRNVU1-9RNA, U1 small nuclear 26, pseudogeneRNA, U1 small nuclear 6, pseudogeneRNA, U1 small nuclear 9, pseudogeneRNA, variant U1 small nuclear 9